205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.91%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
6.12%
Gross profit growth under 50% of AMD's 16.32%. Michael Burry would be concerned about a severe competitive disadvantage.
-72.73%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-72.73%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
372.73%
Positive net income growth while AMD is negative. John Neff might see a big relative performance advantage.
200.00%
Positive EPS growth while AMD is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
200.00%
Positive diluted EPS growth while AMD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.25%
Slight or no buybacks while AMD is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.48%
Slight or no buyback while AMD is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.25%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
786.67%
OCF growth 1.25-1.5x AMD's 551.69%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
125.30%
Positive FCF growth while AMD is negative. John Neff would see a strong competitive edge in net cash generation.
11.86%
Positive 10Y revenue/share CAGR while AMD is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-14.43%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-35.92%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
11.67%
Positive OCF/share growth while AMD is negative. John Neff might see a comparative advantage in operational cash viability.
-24.52%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-54.44%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-61.41%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-82.09%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
131.78%
5Y equity/share CAGR above 1.5x AMD's 4.57%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
60.37%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
87.55%
Dividend/share CAGR of 87.55% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
14.29%
Stable or rising mid-term dividends while AMD is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
37.39%
Our short-term dividend growth is positive while AMD cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-5.10%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-9.02%
Inventory is declining while AMD stands at 8.73%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.16%
Negative asset growth while AMD invests at 15.79%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.55%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.23%
We’re deleveraging while AMD stands at 65.76%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.71%
Our R&D shrinks while AMD invests at 8.62%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.55%
SG&A growth well above AMD's 14.72%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.